NeuVasQ is developing pharmaceutical treatments to restore the blood-brain barrier function in acute neurological disorders such as stroke and epilepsy, and in neurodegenerative disorders like Alzheimer’s disease. Disruptive technology NeuVasQ Biotechnologies, a spin-off from the Université Libre de Bruxelles (ULB), is developing pharmaceuticals to sustain or restore the neurovascular function,…
Read More